Millar A B, Miller R F, Patou G, Mindel A, Marsh R, Semple S J
University College and Middlesex School of Medicine, London.
Genitourin Med. 1990 Jun;66(3):156-8. doi: 10.1136/sti.66.3.156.
Sixteen patients with the Acquired Immunodeficiency Syndrome (AIDS) and cytomegalovirus retinitis were treated with ganciclovir alone (9 patients) or ganciclovir and zidovudine (6 patients). The duration of effective treatment, that is the number of weeks during which there was no deterioration in visual symptoms or retinal appearance, was comparable in both groups. However, six of the seven patients receiving concurrent therapy had to cease treatment temporarily because of bone marrow toxicity compared with one of the nine patients treated with ganciclovir alone. It is concluded that continuous concurrent therapy with oral zidovudine and intravenous ganciclovir is not possible unless unlimited supportive therapy including blood transfusion, is available.
16例获得性免疫缺陷综合征(艾滋病)合并巨细胞病毒性视网膜炎的患者接受了更昔洛韦单药治疗(9例)或更昔洛韦与齐多夫定联合治疗(6例)。两组的有效治疗持续时间,即视觉症状或视网膜外观无恶化的周数相当。然而,接受联合治疗的7例患者中有6例因骨髓毒性不得不暂时停止治疗,而单用更昔洛韦治疗的9例患者中只有1例出现这种情况。得出的结论是,除非有包括输血在内的无限制支持治疗,否则口服齐多夫定和静脉注射更昔洛韦的持续联合治疗是不可能的。